Novo Nordisk Sues Pharmacies Over Impure Wegovy, Ozempic Dupes • MV TELEGRAPH
A 0.25 mg injection pen of Novo Nordisk's weight loss drug Wegovy is shown in this photo in Oslo, Norway, on Aug. 31, 2023.
Stay updated with breaking news from Pharmacy Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A 0.25 mg injection pen of Novo Nordisk's weight loss drug Wegovy is shown in this photo in Oslo, Norway, on Aug. 31, 2023.
The Danish drugmaker claims one pharmacy is adding a banned substance to its drugs.
The lawsuits come as Novo Nordisk grapples with shortages of Wegovy and Ozempic in the U.S. due to skyrocketing demand.
The lawsuits come as Novo Nordisk grapples with shortages of Wegovy and Ozempic in the U.S. due to skyrocketing demand.
Maintaining a thriving independent pharmacy requires strategic thinking and innovative approaches to increase revenue. There are lots of ways to boost those numbers. Some are obvious like "expand your clinical service offerings" or "leverage technology" to up your med sync game, for instance, or even launch a mobile app to make it easier for patients. But thinking outside the proverbial box has never been more critical (or easier).